by Eric Christianson | Jan 26, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I recently received a text from a friend about the use of oral semaglutide in a patient with diabetes. It is definitely exciting to have more options for patients, even though we know there will inevitably be insurance coverage hurdles to jump through. Here are a few...
by Eric Christianson | Jan 22, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Oftentimes there are numerous agents within a class of medication. Ropinirole (Requip) and pramipexole (Mirapex) is an example of this. When comparing ropinirole and pramipexole, there are clinical differences that might alter which one you choose. Comparing...
by Eric Christianson | Jan 19, 2020 | Clinical Pharmacy News and New Drug Updates
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this...
by Eric Christianson | Jan 15, 2020 | Pharmacist Legislative Advocacy
2020 Pharmacist Provider Status is being considered by the Trump administration. This is a good thing for the profession and more importantly, a good thing for patients. There were a couple of quotes from CMS Administrator Seema Verma with regards to provider status...
by Eric Christianson | Jan 12, 2020 | Gastrointestinal Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
In this case study, we discuss a situation where a drug causes a higher pH in the stomach. The elevated pH from an antacid can impact the absorption of other drugs. A 44-year-old female presents to the clinic with Strep throat. Her current medications include...
